Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments


May 2009
Biopharmaceutical company Hybrigenics, based in Paris, has signed a contract as part of the European Union research project Masterswitch. The company will receive more than €400,000 over the first two years of the five-year agreement, which will enable it to develop a high-throughput assay and attempt to identify small-molecule inhibitors of a protein reaction found in chronic inflammatory diseases.

BiophotonicsHybrigenicsMasterswitchNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!